3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Glioblastoma
2
Spondylitis, Ankylosing
1
Signs and Symptoms
1
Psoriasis
1
Nutrition Disorders
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Insulin Resistance
1
Inflammatory Bowel Diseases
1
Glioma
1
Gastroparesis
1
Feeding and Eating Disorders
1
Esophageal Neoplasms
1
Epilepsy
1
Dumping Syndrome
1
Diarrhea
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Cisplatin
109
Radiotherapy
100
Fluorouracil
90
Paclitaxel
75
Oxaliplatin
63
Docetaxel
56
Carboplatin
55
Irinotecan
41
Esophagectomy
41
Leucovorin
40
Capecitabine
39
Radiation
36
Surgical Procedures, Operative
35
Drug Therapy
31
Neoadjuvant Therapy
25
Chemoradiotherapy
18
Cetuximab
18
S 1 (combination)
17
pembrolizumab
16
camrelizumab
16
Nivolumab
15
Magnetic Resonance Spectroscopy
15
Bevacizumab
15
Blood Specimen Collection
14
Surveys and Questionnaires
12
Radiotherapy, Intensity-Modulated
12
Immunotherapy
11
Epirubicin
11
Biopsy
11
Trastuzumab
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Esophageal Neoplasms
×
Sulfasalazine
×
Clear all
NCT03734627
2021-08-16
EndoGut
St. James's Hospital, Ireland
Completed
40 enrolled